{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:58:12Z","timestamp":1792205892712,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-05931-y","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:54:43Z","timestamp":1779465283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of artemether-lumefantrine for uncomplicated plasmodium falciparum malaria treatment in Mozambique: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Abel","family":"Nhama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Torres-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosauro","family":"Varo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e9nio","family":"Nhacolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"5931_CR1","unstructured":"World Health Organization. World malaria report 2021. World Health Organization; 2021."},{"key":"5931_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-3156.2002.00831.x","volume":"7","author":"F Saute","year":"2002","unstructured":"Saute F, Menendez C, Mayor A, Aponte J, Gomez-Olive X, Dgedge M, et al. Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health. 2002;7:19\u201328. https:\/\/doi.org\/10.1046\/j.1365-3156.2002.00831.x.","journal-title":"Trop Med Int Health"},{"key":"5931_CR3","volume-title":"Mo\u00e7ambique Inqu\u00e9rito Demogr\u00e1fico e de Sa\u00fade 2011","author":"Ministerio da Saude (MISAU)","year":"2013","unstructured":"Ministerio da Saude (MISAU), Instituto Nacional de Estat\u00edstica (INE), ICF International (ICFI). Mo\u00e7ambique Inqu\u00e9rito Demogr\u00e1fico e de Sa\u00fade 2011. Calverton, Maryland, USA: MISAU, INE e ICFI; 2013."},{"key":"5931_CR4","doi-asserted-by":"crossref","unstructured":"Maulide Cane R, Muhumuza Kananura R, Wasswa R, Gon\u00e7alves MP, Varandas L, Craveiro I. Childhood anemia in Mozambique: a multilevel mixed-effects analysis of 2011\u20132022\/23 population-based surveys. InHealthcare (Vol. 13, No. 6, p. 635). MDPI 2025.","DOI":"10.3390\/healthcare13060635"},{"key":"5931_CR5","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc0805011","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith B, Socheat D, Fukuda M. Evidence of Artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008. https:\/\/doi.org\/10.1056\/nejmc0805011.","journal-title":"N Engl J Med"},{"key":"5931_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/nejmoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367. https:\/\/doi.org\/10.1056\/nejmoa0808859. (Massachusetts Medical Society).","journal-title":"N Engl J Med"},{"issue":"12","key":"5931_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1056\/NEJMc090023","volume":"360","author":"RN Price","year":"2009","unstructured":"Price RN, Dorsey G, Nosten F. Antimalarial therapies in children from Papua New Guinea. N Engl J Med. 2009;360(12):1254.","journal-title":"N Engl J Med"},{"key":"5931_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135. https:\/\/doi.org\/10.1038\/nature12876.","journal-title":"Nature"},{"key":"5931_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(21)00142-0. (Lancet Publishing Group;).","journal-title":"Lancet Infect Dis"},{"key":"5931_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/nejmoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of Artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371. https:\/\/doi.org\/10.1056\/nejmoa2101746. (Massachusetts Medical Society;).","journal-title":"N Engl J Med"},{"key":"5931_CR11","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd editio. Geneva , Switzerland: world Health Organozation; 2015.","edition":"3rd editio"},{"key":"5931_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-309","author":"A Nhama","year":"2014","unstructured":"Nhama A, Bassat Q, Enosse S, Nhacolo A, Mutemba R, Carvalho E, et al. In vivo efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for the treatment of uncomplicated falciparum malaria in children: A multisite, open-label, two-cohort, clinical trial in Mozambique. Malar J. 2014. https:\/\/doi.org\/10.1186\/1475-2875-13-309. (BioMed Central Ltd.;).","journal-title":"Malar J"},{"key":"5931_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.actatropica.2017.03.032","volume":"171","author":"C Salvador","year":"2017","unstructured":"Salvador C, Rafael B, Matsinhe F, Candrinho B, Muthemba R, De Carvalho E, et al. Efficacy and safety of Artemether\u2013Lumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, 2015. Acta Trop. 2017;171:146\u201350. https:\/\/doi.org\/10.1016\/j.actatropica.2017.03.032. (Elsevier B.V.;).","journal-title":"Acta Trop"},{"key":"5931_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03922-9","author":"A Nhama","year":"2021","unstructured":"Nhama A, Nham\u00fassua L, Macete E, Bassat Q, Salvador C, Enosse S, et al. In vivo efficacy and safety of artemether\u2013lumefantrine and amodiaquine\u2013artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. Malar J. 2021. https:\/\/doi.org\/10.1186\/s12936-021-03922-9.","journal-title":"Malar J"},{"key":"5931_CR15","unstructured":"World Health Organization. Artemisinin resistance and artemisinin-based combination therapy efficacy: status report. World Health Organization; 2018."},{"key":"5931_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119215","author":"C Escobar","year":"2015","unstructured":"Escobar C, Pateira S, Lobo E, Lobo L, Teodosio R, Dias F, et al. Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0119215.","journal-title":"PLoS ONE"},{"issue":"1","key":"5931_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3201\/eid2401.170864","volume":"24","author":"H Gupta","year":"2018","unstructured":"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-resistant polymorphisms and copy numbers in Plasmodium falciparum, Mozambique, 2015. Emerg infect dis. 2018;24(1):40.","journal-title":"Emerg infect dis"},{"key":"5931_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03930-9","author":"A Chidimatembue","year":"2021","unstructured":"Chidimatembue A, Svigel SS, Mayor A, A\u00edde P, Nhama A, Nhamussua L, et al. Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018. Malar J. 2021. https:\/\/doi.org\/10.1186\/s12936-021-03930-9.","journal-title":"Malar J"},{"key":"5931_CR19","unstructured":"World Health Organization. Methods for surveillance of antimalarial drug efficacy 2009."},{"key":"5931_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmj.n71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. statement: An updated guideline for reporting systematic reviews. The BMJ. 2020;2021:372. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"The BMJ"},{"key":"5931_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"5931_CR22","doi-asserted-by":"crossref","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR. RoB 2: a revised tool for assessing risk of bias in randomised trials. bmj. 2019; 366.","DOI":"10.1136\/bmj.l4898"},{"key":"5931_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-21416-0","volume-title":"General package for meta-analysis","author":"G Schwarzer","year":"2015","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G. General package for meta-analysis. Cham: Springer International Publishing; 2015. https:\/\/doi.org\/10.1007\/978-3-319-21416-0."},{"key":"5931_CR24","volume-title":"A language and environment for statistical computing","author":"Team RC","year":"2020","unstructured":"Team RC. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020."},{"key":"5931_CR25","first-page":"15","volume":"2013","author":"HJ Sch\u00fcnemann","year":"2013","unstructured":"Sch\u00fcnemann HJ, Bro\u017cek J, Guyatt G, Oxman A. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October. 2013;2013:15.","journal-title":"Updated October."},{"key":"5931_CR26","unstructured":"World Health Organization. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019). World Health Organization; 2020."},{"issue":"9652","key":"5931_CR27","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(08)61492-0","volume":"372","author":"S Abdulla","year":"2008","unstructured":"Abdulla S, Sagara I, Borrmann S, D\u2019Alessandro U, Gonz\u00e1lez R, Hamel M, et al. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet. 2008;372(9652):1819\u201327.","journal-title":"Lancet"},{"key":"5931_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","volume":"375","author":"AK Tshefu","year":"2010","unstructured":"Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SSS, et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemetherlumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet. 2010;375:1457\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(10)60322-4.","journal-title":"Lancet"},{"key":"5931_CR29","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/cid\/ciw029","volume":"62","author":"OA Toure","year":"2016","unstructured":"Toure OA, Valecha N, Tshefu AK, Thompson R, Krudsood S, Gaye O, et al. A phase 3, double-blind, randomized study of arterolane maleate-piperaquine phosphate vs artemether-lumefantrine for falciparum malaria in adolescent and adult patients in Asia and Africa. Clin Infect Dis. 2016;62:964\u201371. https:\/\/doi.org\/10.1093\/cid\/ciw029. (Oxford University Press;).","journal-title":"Clin Infect Dis"},{"key":"5931_CR30","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/cid\/cix617","volume":"65","author":"OA Toure","year":"2017","unstructured":"Toure OA, Mwapasa V, Sagara I, Gaye O, Thompson R, Maheshwar AV, et al. Assessment of efficacy and safety of arterolane maleate-piperaquine phosphate dispersible tablets in comparison with artemether-lumefantrine dispersible tablets in pediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase 3, randomized, multicenter trial in India and Africa. Clin Infect Dis. 2017;65:1711\u201320. https:\/\/doi.org\/10.1093\/cid\/cix617. (Oxford University Press;).","journal-title":"Clin Infect Dis"},{"key":"5931_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tmaid.2007.08.007","volume":"6","author":"S Toovey","year":"2008","unstructured":"Toovey S. Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malaria. Travel Med Infect Dis. 2008;6:29\u201331. https:\/\/doi.org\/10.1016\/j.tmaid.2007.08.007.","journal-title":"Travel Med Infect Dis"},{"key":"5931_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007871","author":"Q Bassat","year":"2009","unstructured":"Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Men\u00e9ndez C, et al. Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS ONE. 2009. https:\/\/doi.org\/10.1371\/journal.pone.0007871.","journal-title":"PLoS ONE"},{"key":"5931_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05473-9","volume":"24","author":"A Nhama","year":"2025","unstructured":"Nhama A, Chidimatembue A, Nhamussua L, Bassat Q, Da Silva C, Nhacolo A, et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022. Malar J. 2025;24:231. https:\/\/doi.org\/10.1186\/s12936-025-05473-9.","journal-title":"Malar J"},{"key":"5931_CR34","unstructured":"World Health Organization. High burden to high impact: a targeted malaria response. 2018."},{"key":"5931_CR35","unstructured":"MISAU\/DNSP\/PNCM. Normas de Tramento da mal\u00e1ria em Mo\u00e7ambique. 2017"},{"key":"5931_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-369","author":"Q Bassat","year":"2011","unstructured":"Bassat Q, Gonz\u00e1lez R, MacHevo S, Nahum A, Lyimo J, Maiga H, et al. Similar efficacy and safety of artemether-lumefantrine (Coartem\u00ae) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malar J. 2011. https:\/\/doi.org\/10.1186\/1475-2875-10-369.","journal-title":"Malar J"},{"key":"5931_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7371681","author":"A Derbie","year":"2020","unstructured":"Derbie A, Mekonnen D, Adugna M, Yeshitela B, Woldeamanuel Y, Abebe T. Therapeutic efficacy of artemether-lumefantrine (Coartem\u00ae) for the treatment of uncomplicated falciparum malaria in Africa: A systematic review. J Parasitol Res. 2020. https:\/\/doi.org\/10.1155\/2020\/7371681.","journal-title":"J Parasitol Res"},{"key":"5931_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264339","author":"K Marwa","year":"2022","unstructured":"Marwa K, Kapesa A, Baraka V, Konje E, Kidenya B, Mukonzo J, et al. Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0264339.","journal-title":"PLoS ONE"},{"key":"5931_CR39","unstructured":"World Health Organization. WHO guidelines for malaria, 2023. WHO. 2023. http:\/\/apps.who.int\/bookorders."},{"key":"5931_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04997-7","author":"C da Silva","year":"2023","unstructured":"da Silva C, Boene S, Datta D, Rovira-Vallbona E, Aranda-D\u00edaz A, Cister\u00f3 P, et al. Targeted and whole-genome sequencing reveal a north-south divide in P. falciparum drug resistance markers and genetic structure in Mozambique. Commun Biol. 2023. https:\/\/doi.org\/10.1038\/s42003-023-04997-7.","journal-title":"Commun Biol"},{"key":"5931_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02166-w","volume":"15","author":"S Boene","year":"2025","unstructured":"Boene S, Rovira-Vallbona E, da Silva C, Garc\u00eda-Ulloa M, Rafael B, Canana N, et al. Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities in 2021 and 2022. Sci Rep. 2025;15:29335. https:\/\/doi.org\/10.1038\/s41598-025-02166-w.","journal-title":"Sci Rep"},{"key":"5931_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03745-8","author":"A Abamecha","year":"2021","unstructured":"Abamecha A, Yilma D, Adissu W, Yewhalaw D, Abdissa A. Efficacy and safety of artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: A systematic review and meta-analysis. Malar J. 2021. https:\/\/doi.org\/10.1186\/s12936-021-03745-8.","journal-title":"Malar J"},{"key":"5931_CR43","unstructured":"World Health Organization. Multiple first-line therapies as part of the response to antimalarial drug resistance: an implementation guide. World Health Organization; 2024."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05931-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:22:39Z","timestamp":1786936959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05931-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5931"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05931-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This review protocol was not subject to ethical approval or consent to participate; however, it was registered on the International Prospective Register of Systematic Reviews (PROSPERO) on 22 October 2022, under registration number 369991.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"264"}}